AstraZeneca Prilosec Patent Trial Hinges On Definition Of “Subcoating”

The outcome of AstraZeneca's Prilosec patent case will likely hinge on the Manhattan federal court's interpretation of the term "subcoating.

More from Archive

More from Pink Sheet